No Data
No Data
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, With Gross Profit Rising 21%
Cosmos Health Files Secondary Offering of Shares
Cosmos Health Reports Robust Sales of Proprietary Brands on Amazon UK
Cosmos Health Reports 160% Increase In 2024 YTD Sales Of Proprietary Brands On Amazon UK, Reaching $596K Compared To $230K In 2023
Cosmos Health Gets Over $500,000 in UK Initial Orders for Antimicrobial Wash
Cosmos Health Receives Initial Orders Exceeding $500,000 For C-Scrub In The UK; Future Orders Booked At Accelerated Pace With Strong Profitability Anticipated Due To High Profit Margins
No Data
No Data